CYCLERION THERAPEUTICS INC (CYCN:NASDAQ)
$3.18 0.03 (0.9524%)
Analysed CYCLERION THERAPEUTICS INC (CYCN:NASDAQ) News Sources
Akebia Therapeutics Sets Rare Kidney Drug Plan After Q32 Bio Deal
01-12-2025
yahoo.com
Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression
05-01-2026
yahoo.com
BC-Most Active Stocks
06-01-2026
yahoo.com
CYCN: Engineering a Reset; Initiating Coverage of Cyclerion Therapeutics…
02-02-2026
yahoo.com
Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
17-02-2026
yahoo.com
CYCN: Positive Feedback from FDA Sets Stage for Phase 2 Trial of CYC-126 in 2H26
23-02-2026
yahoo.com
Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement
01-04-2026
yahoo.com
Top Midday Gainers
01-04-2026
yahoo.com
Penny Stock CYCN Surged More Than 300% Yesterday. Why, And Should You Chase the Rally Here?
02-04-2026
barchart.com
Cyclerion Therapeutics (CYCN) Merges With Korsana Biosciences to Advance Alzheimer’s Pipeline
20-04-2026
yahoo.com
What is the current price of CYCLERION THERAPEUTICS INC (CYCN:NASDAQ)?
The current price of CYCLERION THERAPEUTICS INC (CYCN:NASDAQ) is $3.18.
CYCLERION THERAPEUTICS INC (CYCN:NASDAQ) absolute price change since previous trading day?
The absolute price change of CYCLERION THERAPEUTICS INC (CYCN:NASDAQ) since the previous trading day is $0.03.
CYCLERION THERAPEUTICS INC (CYCN:NASDAQ) percentage price change since previous trading day?
The percentage price change of CYCLERION THERAPEUTICS INC (CYCN:NASDAQ) since the previous trading day is 0.9524%.
What is the most recent average sentiment score for CYCLERION THERAPEUTICS INC (CYCN:NASDAQ)?
The most recent average sentiment score for CYCLERION THERAPEUTICS INC (CYCN:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for CYCLERION THERAPEUTICS INC (CYCN:NASDAQ)?
The most recent sentiment for CYCLERION THERAPEUTICS INC (CYCN:NASDAQ) is .
SEC-8K** Filing Available For CYCLERION THERAPEUTICS INC (CYCN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.